Review



trem2 stainings biotinylated secondary antibody  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Vector Laboratories trem2 stainings biotinylated secondary antibody
    HX600 reduces Iba-1, phospho-p38 and <t>TREM2</t> immunoreactivities in the ischemic brain. Quantitative analysis of the Iba-1, phospho-p38 and TREM2 immunoreactivities (A–C), and typical representative images of group receiving vehicle (D–F) or HX600 treatment (G–I) at time point 1 day after the insult. Immunoreactivities of Iba-1 and phospho-p38 were analyzed from the peri-ischemic area, and TREM2 at the lesion site. Scale bar 100 μm. Data presented as mean ± SD. Unpaired two-tailed t-test, n = 8 in each group. *p < 0.05 ***p < 0.001.
    Trem2 Stainings Biotinylated Secondary Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 9822 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+stainings+biotinylated+secondary+antibody/Biotinylated+Anti-Avidin+Antibody/pmc08543705-124-3-10
    Average 96 stars, based on 9822 article reviews
    trem2 stainings biotinylated secondary antibody - by Bioz Stars, 2026-10
    96/100 stars

    Images

    1) Product Images from "HX600, a synthetic agonist for RXR-Nurr1 heterodimer complex, prevents ischemia-induced neuronal damage"

    Article Title: HX600, a synthetic agonist for RXR-Nurr1 heterodimer complex, prevents ischemia-induced neuronal damage

    Journal: Brain, behavior, and immunity

    doi: 10.1016/j.bbi.2018.07.021

    HX600 reduces Iba-1, phospho-p38 and TREM2 immunoreactivities in the ischemic brain. Quantitative analysis of the Iba-1, phospho-p38 and TREM2 immunoreactivities (A–C), and typical representative images of group receiving vehicle (D–F) or HX600 treatment (G–I) at time point 1 day after the insult. Immunoreactivities of Iba-1 and phospho-p38 were analyzed from the peri-ischemic area, and TREM2 at the lesion site. Scale bar 100 μm. Data presented as mean ± SD. Unpaired two-tailed t-test, n = 8 in each group. *p < 0.05 ***p < 0.001.
    Figure Legend Snippet: HX600 reduces Iba-1, phospho-p38 and TREM2 immunoreactivities in the ischemic brain. Quantitative analysis of the Iba-1, phospho-p38 and TREM2 immunoreactivities (A–C), and typical representative images of group receiving vehicle (D–F) or HX600 treatment (G–I) at time point 1 day after the insult. Immunoreactivities of Iba-1 and phospho-p38 were analyzed from the peri-ischemic area, and TREM2 at the lesion site. Scale bar 100 μm. Data presented as mean ± SD. Unpaired two-tailed t-test, n = 8 in each group. *p < 0.05 ***p < 0.001.

    Techniques Used: Two Tailed Test

    Related Articles

    Avidin-Biotin Assay:

    Article Title: HX600, a synthetic agonist for RXR-Nurr1 heterodimer complex, prevents ischemia-induced neuronal damage
    Article Snippet: Fluorescent Alexa 488 or 568-conjugated secondary antibodies (1:200 dilution, Abcam, Cambridge, UK) were used for visualization of the immunoreactivities. .. For phospho-p38 and TREM2 stainings biotinylated secondary antibody (1:200 dilution, Vector Laboratories, Burlingame, CA, USA) was used, followed by reaction with avidin-biotin complex reagent (1:200 dilution, Vector Laboratories, Burlingame, CA, USA) according to the instructions provided by the manufacturer. .. The bound phospho-p38 immunoreactivity was then visualized by development with nickel-enhanced 3,3′-diaminobenzidine, and TREM2 was visualized following the instructions of Tyramide Signal Amplification -kit (Perkin Elmer, MA, USA).



    Similar Products

    trem2 stainings biotinylated secondary antibody  (Vector Laboratories)
    96
    Vector Laboratories trem2 stainings biotinylated secondary antibody
    HX600 reduces Iba-1, phospho-p38 and <t>TREM2</t> immunoreactivities in the ischemic brain. Quantitative analysis of the Iba-1, phospho-p38 and TREM2 immunoreactivities (A–C), and typical representative images of group receiving vehicle (D–F) or HX600 treatment (G–I) at time point 1 day after the insult. Immunoreactivities of Iba-1 and phospho-p38 were analyzed from the peri-ischemic area, and TREM2 at the lesion site. Scale bar 100 μm. Data presented as mean ± SD. Unpaired two-tailed t-test, n = 8 in each group. *p < 0.05 ***p < 0.001.
    Trem2 Stainings Biotinylated Secondary Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+stainings+biotinylated+secondary+antibody/Biotinylated+Anti-Avidin+Antibody/pmc08543705-124-3-10
    Average 96 stars, based on 1 article reviews
    trem2 stainings biotinylated secondary antibody - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    HX600 reduces Iba-1, phospho-p38 and TREM2 immunoreactivities in the ischemic brain. Quantitative analysis of the Iba-1, phospho-p38 and TREM2 immunoreactivities (A–C), and typical representative images of group receiving vehicle (D–F) or HX600 treatment (G–I) at time point 1 day after the insult. Immunoreactivities of Iba-1 and phospho-p38 were analyzed from the peri-ischemic area, and TREM2 at the lesion site. Scale bar 100 μm. Data presented as mean ± SD. Unpaired two-tailed t-test, n = 8 in each group. *p < 0.05 ***p < 0.001.

    Journal: Brain, behavior, and immunity

    Article Title: HX600, a synthetic agonist for RXR-Nurr1 heterodimer complex, prevents ischemia-induced neuronal damage

    doi: 10.1016/j.bbi.2018.07.021

    Figure Lengend Snippet: HX600 reduces Iba-1, phospho-p38 and TREM2 immunoreactivities in the ischemic brain. Quantitative analysis of the Iba-1, phospho-p38 and TREM2 immunoreactivities (A–C), and typical representative images of group receiving vehicle (D–F) or HX600 treatment (G–I) at time point 1 day after the insult. Immunoreactivities of Iba-1 and phospho-p38 were analyzed from the peri-ischemic area, and TREM2 at the lesion site. Scale bar 100 μm. Data presented as mean ± SD. Unpaired two-tailed t-test, n = 8 in each group. *p < 0.05 ***p < 0.001.

    Article Snippet: For phospho-p38 and TREM2 stainings biotinylated secondary antibody (1:200 dilution, Vector Laboratories, Burlingame, CA, USA) was used, followed by reaction with avidin-biotin complex reagent (1:200 dilution, Vector Laboratories, Burlingame, CA, USA) according to the instructions provided by the manufacturer.

    Techniques: Two Tailed Test